Bonum Certa Men Certa

Insensitivity at the EPO's Management - Part II: Patent Office as a Cancer

Cancer letter



Summary: The EPO's stance on cancer recalled, in light of an altercation from 2013 (patent application no. EP03017743.0, appeal number T0598/12-3.3.02)

THE management of the EPO has resorted to what we consider both unethical and potentially illegal tactics. Union busting has taken such a high priority that every trick out of the book has been harnessed, with help from external (contracted) firms.

During Christmas we were contacted by a person who is able to show us just how jaw-dropping the EPO's management can be with regards (or disregard) to cancer. As a preparatory item, consider the following letter, which is nearly a couple of years old (emphasis with large fonts is ours):

Brussels, March 12th, 2014

M. Benoît Battistelli President - European Patent Office Erhardtstr. 27 80469 Munich Germany

Dear M. Battistelli,

My name is Francesco De Lorenzo and I am the President of the European Cancer Patient Coalition - ECPC, which represents 345 cancer patient organizations in 47 countries.

ECPC regularly engages with its members, EU institutions and international health and cancer care stakeholders to protect and enhance cancer patients’ rights in Europe, making sure that the voice of European citizens, affected by cancer, is heard.

That is why we are addressing you to express our concerns regarding the recent decision from the European Patent Office (EPO), Patent application no. EP03017743.0, appeal number T0598/12-3.3.02 on whether a clinical trial invalidates the request for a new drug patent.

"That is why we are addressing you to express our concerns regarding the recent decision from the European Patent Office (EPO), Patent application no. EP03017743.0, appeal number T0598/12-3.3.02 on whether a clinical trial invalidates the request for a new drug patent."We believe that EPO’s position on the matter should take in due consideration the effects it will have on the future treatment of cancer patients and their ability to dispose of new and innovative drugs. We are concerned, in fact, that EPO’s current interpretation of the matter may make clinical trials more difficult to carry out and hence undermine critical innovation in medicine.

Clinical trials are research studies conducted on patients to evaluate the safety and efficacy of medicines intended to improve their health and provide the necessary scientific data and information to develop new medicines. ECPC believes that patent policy should encourage innovation, particularly innovation arising from clinical trials. A clinical trial cannot and should not be construed as a patent defeating disclosure. Should this happen, there will eventually be serious implications for the development of life-saving medicines.

"We are concerned, in fact, that EPO’s current interpretation of the matter may make clinical trials more difficult to carry out and hence undermine critical innovation in medicine."Patients are not only a fundamental partner in the development of new drugs, but they are also those who will finally benefit from the innovation process. In particular, we strongly believe that it is natural that a patient may discuss his/her participation or clinical experience with their physician and family members. It is clear that patients participating in clinical trials should not be considered as members of the public, but rather key collaborators and important and voluntary participants of the trial. However, given their particular situation and knowledge level, patients cannot be compared either to other clinical trials actors, such as researchers. Hence patients cannot share the same confidentiality responsibility as researchers: this would, in fact, represent an unfair burden over the patients’ shoulders, which does not match patients’ level of biomedical and scientific understanding of clinical trials nor the reason for which they participate in them.

"ECPC believes that patent policy should encourage innovation, particularly innovation arising from clinical trials. A clinical trial cannot and should not be construed as a patent defeating disclosure."Aside from the pure legal perspective, it is to be expected that EPO decision on the 2013 case mentioned before, if implemented, will lead to reduced transparency and/or delay of implementation of new clinical trials, which are both to the detriment of patients’ interests. Reducing transparency will threaten the access to investigational drugs that clinical trials provide for patients. This access is of critical importance for cancer patients, particularly for those whose only treatment option may be a clinical trial.

Alternatively, delaying clinical trials until patent applications are filed, will add undue delay to the very time consuming process of developing a new medicine that could improve patients’ lives. Such patent policy also excludes any innovation that arises during a clinical trial.

"Aside from the pure legal perspective, it is to be expected that EPO decision on the 2013 case mentioned before, if implemented, will lead to reduced transparency and/or delay of implementation of new clinical trials, which are both to the detriment of patients’ interests."In conclusion, we strongly believe that the invention or findings related to a clinical trial should not be considered as “made available to the public” only because patients participate actively to the aforementioned trial. The patients’ unique status, in between collaborators and beneficiaries, makes them a key and vulnerable stakeholder, whose necessities are to be protected. Therefore, we would be glad to engage with EPO and all other relevant stakeholders in order to re-discuss the legal status and responsibilities of patients enrolled in clinical trials.

ECPC also believes that research should be encouraged and that public policy should remove barriers to the conduct of clinical trials, while keeping very high security standards and ensuring ethical conduct.

We hope that you will re-examine the decision in question for the benefit of patients. We remain at your disposal to further discuss the issue.

Sincerely,

Prof. F. De Lorenzo



To see how this relates to the series as a whole stay tuned for future parts. It is clear that patent scope has gone awry at the EPO, for the sake of protectionism, greed, and profit. Remember this when the EPO make claims on "productivity" (however misleading these claims can be) and ponder what this really translates into. ⬆

Recent Techrights' Posts

IBM "Efficiency" is Working One's Way to the Bottom of the Remuneration Scale While Hiding the Stealth Layoffs
People still leaving
Forbes Already Stopped Being a News Site. Now It's a Spam and Propaganda Platform for "Paying Partners" (Companies).
news from Forbes became very scarce
Soap Opera of NVIDIA Marketing in Mainstream Media (Overhyped GPUs and Mindless Buzzwords)
NVIDIA's shares lost about $100 in "value" (or 40% "market cap" decline) in 6-7 weeks
The Boss of Linus Torvalds Has Bad Taste, Takes More Money Connected to Traffickers of Underage Girls for Sexual Exploitation Under the Guise of "Tackling Fraud"
Nothing will ever teach Jim Zemlin that Jeffrey Epstein is bad [...] Even the wife of Mr. Epsteingate was wise enough to keep a distance from it. But not Mr. Zemlin, who profits from rehabilitating abusers.
 
Richard Stallman, Founder of the GNU Project and a Co-founder of the FSF, Still Working With the FSF to Abolish Microsoft's Restricted Boot
Jack M. Germain has just published a lengthy article about GNU Boot
GNU/Linux Has Gained a Lot in Western Europe
Eastern Europe is another matter
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Thursday, November 19, 2026
IRC logs for Thursday, November 19, 2026
It's All About Restricted Boot and Microsoft
Garrett is working with Microsoft staff towards Microsoft agenda
Intercontinental Brigading - Part XXXXXVII - UK Isn't Part of the US or Russia
We have plenty to cover in the coming years
Update on Pocock v. Software in the Public Interest, Inc. (26-1766)
Case reassigned
Calling Frauds "Frauds" is Not Illegal
We are still getting the same vibe; Americans do not understand free speech, even if their country has a First Amendment
Everything is "AI" Now
"More Open Than Open [...] I am constantly amazed at the flexibility of this single word.”
Microsoft Web Sites Paint Mass Layoffs as Opportunities for Those Impacted, Mass Layoffs Alleged to Follow in January (to 'Kill Off' Survivors)
Keeping Up Appearances
Microsoft Outages Accelerate Migrations to Free Software
More than one major outage lately
Richard Stallman's Talks Next Month (Tech de Ciudad de México)
Right now is a very good time to promote Software Freedom because of recent world events
WSJ Leadership Institute as Marketing Spam for Slop and GAFAM/IBM PR
What the heck is "WSJ Leadership Institute"?
Links 19/11/2026: "So Many Crucial Services Are Going Down" and "Government Tech Debt is a National Security Risk" (Outages Blamed on Slop Frenzy)
Links for the day
Gemini Links 19/11/2026: Friends, Slop Harms Learning, and IBM Plex Lagrange Fontpacks
Links for the day
Links 19/11/2026: "Ignorance Has Taken Over" and "Apocalypse Now, Again"
Links for the day
Richard Stallman Still Insists "They" is Plural, Suggests "Perse" Instead
this week
New Video Explains Why Software Patents Are Evil ("Why Software Patents Spark So Much Frustration")
Maybe some patent examiners (who don't mind a Facebook URL) can take a look
Intercontinental Brigading - Part XXXXXVI - Never Showing Up for Their Own Hearings, Just Paying Hired Guns in London to Act as Fall Guys and Proxies With No Comprehension of the Technical Issues (and Sometimes by Bullying Our Lawyers)
Without any qualifications in the subject at hand
Compatible With Software of 30 Years Ago
Old is not bad, sometimes old is better
NVIDIA Corporation Does Not Look Healthy
The bubble will be hard to re-inflate
Gemini Links 19/11/2026: Thinking About Thinking and Discord
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Wednesday, November 18, 2026
IRC logs for Wednesday, November 18, 2026
Lots of IBM Layoffs in Slovakia This Year
Slovakia and Europe at large
There May be Little or No Future for IBM Consulting
IBM is believed to be run by parasites
At Least Three RMS Talks Next Month in Mexico (Richard Stallman Has 8+ Talks in a Month)
And also - possibly with slop - in social control media
Mass Layoffs at Salesforce Foretold by Techrights
Salesforce is dead meat and it's not alone
Gemini Links 18/11/2026: Creativity, MFA Hype, and Presto Music
Links for the day
Links 18/11/2026: More GAFAM/Apple 'Clown Computing' Outages and Deutsche Bank Leak, Banks' Downtimes
Links for the day
Today The Register MS Showed Loyalty to the Pyramid Scheme With Homage of Paid Spam About "AI"
The Register MS is disavowed by its founder, who died a few years ago (The Register MS didn't even mention this)
Staff Union of the European Patent Office (SUEPO) Plans General Assembly Next Week, Vote Planned to Approve 7+ More Months of Strikes
The "Agenda" is the same as what we showed yesterday, but the pattern of the actions varies somewhat
IBM's Red Hat a Microsoft Reseller (Second Day in a Row)
If you want a replacement for Microsoft, look somewhere other than Red Hat
After the Bubble Pops the "AI Experts" (Formerly "Data Scientists" or Whatever) Will Rebrand Themselves Again
Remember blockchains and metaverse?
Links 18/11/2026: "Fossil Fuel Companies Are Undermining Democracy" and "Lawyer Up, Elon"
Links for the day
Intercontinental Brigading - Part XXXXXV - Acts of Hypocrisy (Doing What You Accuse Others of Doing)
connected to my criticism of "Restricted Boot"
Mainstream and Establishment Media Trying to Connect "Open Source" to White-Collar Crimes and Scandals at Fraudulent NVIDIA
An associate us said that "MIT lies to smear OSS"
Lawfare Will Continue in 2027
We're dealing with defiant Microsofters who wrongly assume that accurate reporting that causes them distress somehow makes them entitled to money
On the Concept of Moral Obligations to Make the World a Better Place for Everybody
The world generally becomes better when more people challenge the status quo rather than bow down to masters
Nadella Talks About 60,000 Microsoft Workers Having to Decide Whether to Leave (in the Next 2-3 Weeks), They've Been Put on Notice
Some parts of Microsoft are poised for severe cuts
IBM Moved From Selling Technology to Selling Its Buildings
IBM is trying very hard to silence/crush critics
Staff Union of the European Patent Office (SUEPO) Looking to Extend Industrial Actions and Strikes to Almost 1.5 Years
It says a lot about the media that for 1.5 years staff is on strike in the second-largest organisation in Europe and the media pretends it's not happening
Richard Stallman's Talk in Quito This Week (At Least 5 Talks After That)
He's having a busy end of year
Gemini Links 18/11/2026: "Love For Old Devices" and New Software/Slop-ware Releases
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Tuesday, November 17, 2026
IRC logs for Tuesday, November 17, 2026